Clinical trial
New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes
NCT05728931 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 15, 2022
- Completion date
- January 15, 2032
- Enrollment
- 210 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune encephalitis, paraneoplastic neurological syndrome